NCT03989180

Brief Summary

To evaluate the performance of Check-Cap Imaging System in healthy volunteers in a variety of operating scenarios. The Back recorder unit is the primary module for evaluation The participants DO NOT ingest a capsule and the capsules do not have any radioactive source

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
76

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 6, 2016

Completed
3.1 years until next milestone

First Submitted

Initial submission to the registry

February 10, 2019

Completed
4 months until next milestone

First Posted

Study publicly available on registry

June 18, 2019

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 6, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 6, 2020

Completed
Last Updated

February 17, 2022

Status Verified

February 1, 2022

Enrollment Period

4.9 years

First QC Date

February 10, 2019

Last Update Submit

February 15, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Performance of the C-Scan system in terms of communication between the C-Scan Capsule and the System Track in different locations, positions and configurations.

    The C-Scan System performance will be tested in different versions, configurations and locations. The C-Scan Cap with no radioactive source will be placed on the subject's abdomen and the C-Scan Track will be placed on the subject's back in different locations. The subject will be ask to continue his/her rutine daily activities such as: sleeping, driving a car, watching TV etc for a few days.

    36 months

Interventions

* Subjects will receive detailed instructions (verbally and written) about the normal operation of the recorder and how to handle it during normal daily routine. They will be asked to document all their daily activity in a personal diary (attached) * The recorder will be secured to their lower back to test its functionality

Eligibility Criteria

Age20 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The subject population in this study will be composed of male and female subjects older than 25 and younger than 75 years old that volunteer for the experiment and qualify with the inclusion / exclusion criteria A total of Thirty (30) subjects will be enrolled in this study. All study participants will fit the body dimensions listed below (inclusion criteria) Efforts will be made to maintain balanced numbers between men and women and even distribution of ages.

You may qualify if:

  • Male or female between 20 and 75 years of age
  • Subjects who are generally healthy
  • Subjects who fit the following body dimensions:
  • Height: 150-200 cm
  • Weight : 50-140 Kg
  • BMI: 20-35
  • Subjects who are ready to follow the various physical activities such as: walking, running, sitting, driving, bending etc.
  • Subjects who are free to spend up to 4 days carrying the back recorder system.
  • Sign informed consent Form.

You may not qualify if:

  • Subjects with cancer or other life threatening diseases or conditions
  • Pregnant women
  • Subjects with cardiac pacemaker or any other implanted or external portable medical device (i.e. infusion pumps)
  • Bed-ridden or sedentary subjects
  • Subjects who suffer significant movement limitations (who cannot follow the typical activities of walking, driving, bending, sitting etc.)
  • Morbid Obesity (BMI \> 35)
  • Subjects under custodial care
  • Participation in current clinical study or clinical study within 30 days prior to the procedure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bnai-Zion Medical Center

Haifa, Israel

Location

MeSH Terms

Conditions

Colonic Neoplasms

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal Diseases

Study Officials

  • Boaz Shpigelman

    COO, VP R&D

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Days
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 10, 2019

First Posted

June 18, 2019

Study Start

January 6, 2016

Primary Completion

December 6, 2020

Study Completion

December 6, 2020

Last Updated

February 17, 2022

Record last verified: 2022-02

Locations